Chelation therapy, from a scientific standpoint, revolves around the administration of chelating agents, which are organic compounds capable of forming stable bonds with metal ions. The chelation process involves the formation of coordination complexes, where the chelating agent encircles the target metal, creating a ring-like s
AVAILABLE
Chelation therapy, from a scientific standpoint, revolves around the administration of chelating agents, which are organic compounds capable of forming stable bonds with metal ions. The chelation process involves the formation of coordination complexes, where the chelating agent encircles the target metal, creating a ring-like structure. Ethylenediaminetetraacetic acid (EDTA) is a commonly employed chelating agent in clinical settings. In the context of heavy metal toxicity, chelation therapy operates by facilitating the removal of toxic metals from the body through the formation of water-soluble chelates that can be excreted via urine. Beyond its established utility in heavy metal detoxification, chelation therapy has been explored for its potential cardiovascular benefits. The hypothesis posits that chelation may mitigate atherosclerosis by binding to and removing calcium deposits within arterial walls.
Stellate ganglion block (SGB) - single- or doublesided injection of anesthetic medication into a collection of nerves called the stellate ganglion.
Many patients experienced an alleviation of dysautonomia symptoms following a stellate ganglion block.
Other symptoms that improved or resolved were: anxiety/PTSD, arosmia and parosmi
AVAILABLE
Stellate ganglion block (SGB) - single- or doublesided injection of anesthetic medication into a collection of nerves called the stellate ganglion.
Many patients experienced an alleviation of dysautonomia symptoms following a stellate ganglion block.
Other symptoms that improved or resolved were: anxiety/PTSD, arosmia and parosmia. The positive effects of a stellate ganglion block can sometimes last, but often are temporary (which is fine as it gives the body a 'time-out' to regenerate).
Also available via radiofrequency ablation instead of anesthetic medication.
Prof. Elfriede Leniger-Follert was the head of a research group at the Max Planck Institute at the Institute of Systems Physiology that focussed on the oxygen supply to the brain.
Her discovery at the time was that magnesium could help to widen constricted microvessels again
and normalise the oxygen supply. She discovered this mech
AVAILABLE
Prof. Elfriede Leniger-Follert was the head of a research group at the Max Planck Institute at the Institute of Systems Physiology that focussed on the oxygen supply to the brain.
Her discovery at the time was that magnesium could help to widen constricted microvessels again
and normalise the oxygen supply. She discovered this mechanism of the disease-related narrowing of the microvessels in 1983. This reduces
the oxygen supply to the brain, the retina, the inner ear, the lungs and liver, the kidneys and the feet.
In all circulatory disorders, the outer side of the vascular muscle cells is negatively charged compared to the positively charged inner side
(potassium depolarisation). This reversal is the trigger for the shortening of the ring-shaped vascular muscles, which thus become narrower.
A few years later, she discovered that magnesium ions are capable of reversing the unfavourable charge distribution. This
opens and widens the blood vessels again.
Prof. Leniger-Follert uses direct IV injections into the veins and oxygen concentrators directly after.
We have developed a similar therapy based on the decade long knowledge of our medical team and have adapted her findings to the use with Hyperbaric Oxygen combined with IV treatment with Magnesium NaCl solution.
Magnesium Oxygen Therapy - but literally supercharged.
The principle behind cryotherapy lies in its ability to trigger beneficial responses within the body, such as vasoconstriction and the release of anti-inflammatory molecules. As the cryogenic temperatures envelop the body, they prompt a cascade of reactions that can potentially alleviate symptoms, enhance circulation, and promote
AVAILABLE
The principle behind cryotherapy lies in its ability to trigger beneficial responses within the body, such as vasoconstriction and the release of anti-inflammatory molecules. As the cryogenic temperatures envelop the body, they prompt a cascade of reactions that can potentially alleviate symptoms, enhance circulation, and promote overall well-being.
(Use case: In case of high autoantibody levels, after IVIG Therapy.)
Sublingual Peptide Therapy
EAT Therapy (Epipharyngeal Abrasive Therapy)
Sublingual Peptide Therapy
COMING SOON
EAT Therapy (Epipharyngeal Abrasive Therapy)
EAT Therapy (Epipharyngeal Abrasive Therapy)
EAT Therapy (Epipharyngeal Abrasive Therapy)
WILL NOT BE OFFERED
(H.E.L.P. Apheresis and Antiviral Therapy from our findings are showing better results due to system-wide application (versus local application of EAT) whilst being minimal invasive and pain free. EAT is known to be very painful. Therefore our medical team does not integrate it into our protocols.)
Complement System Therapy
UNDER EVALUATION - RESEARCH ONGOING
(Side effects unknown, insufficient clinical evidence for targeted off-label use.)
Complement inhibitors are administered as subcutaneous infusions, intravenous infusions or oral capsules.
Here is a list of some well-known complement inhibitors (source: RXList):
Anecdotal note: The Complement System seems to return to its normal state after H.E.L.P. Apheresis treatments / Combination Therapy in most patients. Single healing attempts with off-label use of complement system inhibitors are not very common yet and there is little known about the efficiency of the various existing inhibitors in Long Covid.
*Despite emergency use authorisation of certain complement inhibitors for COVID-19, Complement System Treatment will first be available when sufficient clinical evidence is collected for targeted off-label use. One thing to consider is the numerous side-effects of the various complement inhibitors.
Why do we publish this information? We get many enquiries regarding Complement Treatment and want to share what is known so far.
IMPORTANT NOTE: Rituximab and Obinutuzumab despite very similar sounding names are NOT complement inhibitors - they are mABs complement activators and important for B-Cell depletion therapy (which has been mainly researched for multiple sclerosis but is now subject of research in other chronic conditions too)
Patient Reviews
Member of the Cyprus Medical Association
Dr. Irina Pavlik Marangos
Choose Your Language
Apheresis Center, H.E.L.P. Apheresis & Combination Therapy
Our diagnostic screening questionnaire is used by thousands all over the world, clinicians and patients. It gives you an clinical diagnosis on how severely you are affected by microclots, microcirculation and blood flow issues and if further investigation is meaningful.